Xian‐Lu Song
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Oncology
- Biomedical Engineering
- Co-authors
- Shan‐Chao ZhaoChong WangDaojun LvYu‐Zhong YuFangpeng ShuMingkun ChenXinan LiZhanghui Chen
- Topics
- MicroRNA in disease regulation (6 papers)Cancer-related molecular mechanisms research (5 papers)Prostate Cancer Treatment and Research (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xian‐Lu Song
21 papers receiving 755 citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Biology 492
- Cancer Research 287
- Pulmonary and Respiratory Medicine 159
- Oncology 122
- Biomedical Engineering 67
Countries citing papers authored by Xian‐Lu Song
This map shows the geographic impact of Xian‐Lu Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian‐Lu Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian‐Lu Song more than expected).
Fields of papers citing papers by Xian‐Lu Song
This network shows the impact of papers produced by Xian‐Lu Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian‐Lu Song. The network helps show where Xian‐Lu Song may publish in the future.
Co-authorship network of co-authors of Xian‐Lu Song
This figure shows the co-authorship network connecting the top 25 collaborators of Xian‐Lu Song. A scholar is included among the top collaborators of Xian‐Lu Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xian‐Lu Song. Xian‐Lu Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Current therapy and drug resistance in metastatic castration-resistant prostate cancerbreakdown → | 146 |
| 3 | 108 | |
| 4 | 68 | |
| 5 | 7 | |
| 6 | 9 | |
| 7 | 14 | |
| 8 | 57 | |
| 9 | 6 | |
| 10 | 53 | |
| 11 | 88 | |
| 12 | 10 | |
| 13 | 12 | |
| 14 | 34 | |
| 15 | 21 | |
| 16 | 21 | |
| 17 | 52 | |
| 18 | 12 | |
| 19 | 33 | |
| 20 | [Differential expressions of the receptor for advanced glycation end products in prostate cancer and normal prostate]. | 10 |
About Xian‐Lu Song
Xian‐Lu Song is a scholar working on Aging, Cancer Research and Applied Microbiology and Biotechnology, having authored 22 papers that have together received 765 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Aging (42 citations), Cancer Research (287 citations) and Molecular Biology (492 citations). Xian‐Lu Song has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shan‐Chao Zhao, Chong Wang, Daojun Lv, Yu‐Zhong Yu, Fangpeng Shu, Mingkun Chen, Xinan Li, Zhanghui Chen, Dong‐Hua Yang and Bin Huang. Their work appears in journals such as Molecular Cancer, RSC Advances and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.